DAVID B NEWSOME

Allopathic & Osteopathic Physicians|Family Medicine METAIRIE, LA NPI 1932634813

General Payments — all program years on this page

$3,229.82

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 170
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $777.96 across 41 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $777.9641

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $33.752
2019 $114.037
2020 $210.9112
2021 $732.9637
2022 $647.0636
2023 $713.1535
2024 $777.9641

Records — PY2024 (41)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1093964978 Alexion Pharmaceuticals, Inc. $27.90 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097301183 Novo Nordisk Inc $21.46 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104287132 AstraZeneca Pharmaceuticals LP $27.45 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104421773 AstraZeneca Pharmaceuticals LP $16.37 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104463218 AstraZeneca Pharmaceuticals LP $21.60 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104536687 AstraZeneca Pharmaceuticals LP $20.49 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104608052 AstraZeneca Pharmaceuticals LP $18.24 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104722599 AstraZeneca Pharmaceuticals LP $15.84 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114434 ABBVIE INC. $22.21 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114436 ABBVIE INC. $16.27 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114438 ABBVIE INC. $29.61 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114440 ABBVIE INC. $16.95 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114442 ABBVIE INC. $34.51 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114444 ABBVIE INC. $14.39 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114446 ABBVIE INC. $26.94 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114448 ABBVIE INC. $23.62 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114450 ABBVIE INC. $10.77 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114452 ABBVIE INC. $7.24 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114454 ABBVIE INC. $26.69 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114456 ABBVIE INC. $10.77 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114458 ABBVIE INC. $5.65 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105114460 ABBVIE INC. $6.59 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105729661 AstraZeneca Pharmaceuticals LP $20.80 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114807734 Exact Sciences Corporation $24.67 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116249334 GlaxoSmithKline, LLC. $19.33 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116629510 GlaxoSmithKline, LLC. $16.60 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117338691 Amgen Inc. $13.93 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125346909 Abbott Laboratories $16.56 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131509305 PFIZER INC. $17.10 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136121936 Lilly USA, LLC $14.43 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136152922 Lilly USA, LLC $18.10 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139286692 Astellas Pharma US Inc $18.63 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139336146 Astellas Pharma US Inc $16.87 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139390702 Astellas Pharma US Inc $16.40 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141771916 Merck Sharp & Dohme LLC $14.13 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146781954 IDORSIA PHARMACEUTICALS US INC $16.21 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148896165 Sumitomo Pharma America, Inc. $26.66 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148896167 Sumitomo Pharma America, Inc. $20.93 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148896169 Sumitomo Pharma America, Inc. $21.90 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148896171 Sumitomo Pharma America, Inc. $22.99 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153427108 Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.16 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.